SEVO Bioscience Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Later Stage VC
- Investors
-
10
SEVO Bioscience General Information
Description
Developer of microalgae-based oral vaccines designed for sustainable disease prevention in aquaculture. The company utilizes synthetic biology and genetic engineering to produce antigens within microalgae strains, enabling the delivery of lifelong immune support through pelletized feed supplements, providing the aquaculture industry with a stress-free alternative to traditional injectable treatments.
Contact Information
Website
www.sevobioscience.comCorporate Office
- 7147 Rue Sherbrooke O
- Montreal, Quebec H4B 1R9
- Canada
Corporate Office
- 7147 Rue Sherbrooke O
- Montreal, Quebec H4B 1R9
- Canada
SEVO Bioscience Timeline
SEVO Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 08-Sep-2026 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 23-Jul-2025 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 29-Apr-2024 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 15-Feb-2024 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 03-May-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 05-Oct-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
SEVO Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SEVO Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SEVO Bioscience Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cape Breton Capital Group | Angel Group | Minority | ||
| Bioenterprise Canada | Not-For-Profit Venture Capital | |||
| Invest Nova Scotia | Venture Capital | Minority | ||
| Cycle Momentum | Accelerator/Incubator | |||
| Québec Tech | Accelerator/Incubator |
SEVO Bioscience FAQs
-
When was SEVO Bioscience founded?
SEVO Bioscience was founded in 2019.
-
Where is SEVO Bioscience headquartered?
SEVO Bioscience is headquartered in Montreal, Canada.
-
What is the size of SEVO Bioscience?
SEVO Bioscience has 4 total employees.
-
What industry is SEVO Bioscience in?
SEVO Bioscience’s primary industry is Drug Discovery.
-
Is SEVO Bioscience a private or public company?
SEVO Bioscience is a Private company.
-
What is SEVO Bioscience’s current revenue?
The current revenue for SEVO Bioscience is .
-
How much funding has SEVO Bioscience raised over time?
SEVO Bioscience has raised $100K.
-
Who are SEVO Bioscience’s investors?
Cape Breton Capital Group, Bioenterprise Canada, Invest Nova Scotia, Cycle Momentum, and Québec Tech are 5 of 10 investors who have invested in SEVO Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
